85 related articles for article (PubMed ID: 2793358)
1. The intravitreal penetration of ceftriaxone in man following systemic administration.
Sharir M; Triester G; Kneer J; Rubinstein E
Invest Ophthalmol Vis Sci; 1989 Oct; 30(10):2179-83. PubMed ID: 2793358
[TBL] [Abstract][Full Text] [Related]
2. The intravitreal penetration of orally administered ciprofloxacin in humans.
Keren G; Alhalel A; Bartov E; Kitzes-Cohen R; Rubinstein E; Segev S; Treister G
Invest Ophthalmol Vis Sci; 1991 Jul; 32(8):2388-92. PubMed ID: 2071350
[TBL] [Abstract][Full Text] [Related]
3. The penetration of gentamicin into the vitreous humor in man.
Rubinstein E; Goldfarb J; Keren G; Blumenthal M; Treister G
Invest Ophthalmol Vis Sci; 1983 May; 24(5):637-9. PubMed ID: 6841012
[TBL] [Abstract][Full Text] [Related]
4. The intravitreal penetration of cefotaxime in man following systemic and subconjunctival administrations.
Rubinstein E; Triester G; Avni I; Schwartzkopf R
Ophthalmology; 1987 Jan; 94(1):30-4. PubMed ID: 3561954
[TBL] [Abstract][Full Text] [Related]
5. Cefuroxime versus ceftriaxone prophylaxis in cardiovascular surgery.
Geroulanos S; Donfried B; Schumacher F; Turina M
Drugs Exp Clin Res; 1985; 11(3):201-5. PubMed ID: 3915287
[TBL] [Abstract][Full Text] [Related]
6. Aqueous and vitreous penetration of ciprofloxacin following different modes of systemic administration.
Madu AA; Mayers M; Perkins R; Liu W; Drusano GL; Aswani R; Madu CN; Miller MH
Exp Eye Res; 1996 Aug; 63(2):129-36. PubMed ID: 8983970
[TBL] [Abstract][Full Text] [Related]
7. Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection.
Inoue M; Takeda K; Morita K; Yamada M; Tanigawara Y; Oguchi Y
Am J Ophthalmol; 2004 Dec; 138(6):1046-8. PubMed ID: 15629301
[TBL] [Abstract][Full Text] [Related]
8. A study of plasma and cardiac tissue concentrations of ceftriaxone (Rocephin) in open heart surgery.
Faragó E; Szécsi J; Péterffy A; Mihóczy L
Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):358-61. PubMed ID: 2777425
[TBL] [Abstract][Full Text] [Related]
9. [Diffusion of ceftriaxone into the human brain].
Dorche G; Lucht F; Bertrand AM; Vinhas E; Gibaud H; Aubert G; Brunon J
Pathol Biol (Paris); 1990 Jun; 38(6):638-42. PubMed ID: 2374699
[TBL] [Abstract][Full Text] [Related]
10. Vitreous and aqueous penetration of orally administered moxifloxacin in humans.
Vedantham V; Lalitha P; Velpandian T; Ghose S; Mahalakshmi R; Ramasamy K
Eye (Lond); 2006 Nov; 20(11):1273-8. PubMed ID: 16200061
[TBL] [Abstract][Full Text] [Related]
11. Vitreal penetration of oral moxifloxacin in humans.
Lott MN; Fuller JJ; Hancock HA; Singh J; Singh H; McGwin G; Marcus DM
Retina; 2008 Mar; 28(3):473-6. PubMed ID: 18327141
[TBL] [Abstract][Full Text] [Related]
12. Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration.
Hariprasad SM; Mieler WE; Shah GK; Blinder KJ; Apte RS; Holekamp NM; Thomas MA; Chi J; Prince RA
Trans Am Ophthalmol Soc; 2004; 102():149-55; discussion 155-7. PubMed ID: 15747753
[TBL] [Abstract][Full Text] [Related]
13. Aqueous and vitreous penetration of linezolid (Zyvox) after oral administration.
Fiscella RG; Lai WW; Buerk B; Khan M; Rodvold KA; Pulido JS; Labib S; Shapiro MJ; Blair NP
Ophthalmology; 2004 Jun; 111(6):1191-5. PubMed ID: 15177970
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the relationship between serum and milk residue disposition of ceftriaxone in lactating ewes.
Goudah A; Shin HC; Shim JH; Abd El-Aty AM
J Vet Pharmacol Ther; 2006 Aug; 29(4):307-12. PubMed ID: 16846468
[TBL] [Abstract][Full Text] [Related]
15. Determination of cephazolin, ceftazidime, and ceftriaxone distribution in nucleus pulposus.
Yan D; Li J; Zhang Z; Zhu H
Arch Orthop Trauma Surg; 2012 Jul; 132(7):969-73. PubMed ID: 22526195
[TBL] [Abstract][Full Text] [Related]
16. Vitreal penetration of oral and topical moxifloxacin in humans.
Fuller JJ; Lott MN; Henson NM; Bhatti AA; Singh H; McGwin G; Marcus DM
Am J Ophthalmol; 2007 Feb; 143(2):338-40. PubMed ID: 17258525
[TBL] [Abstract][Full Text] [Related]
17. Distribution of ceftriaxone in the tissues of the female genital system.
Fraschini F; Zoncada F; Scaglione F; Radaelli U; Miraglia M; Valmaggi P; Falchi M; Ripamonti L
Int J Clin Pharmacol Res; 1987; 7(6):499-502. PubMed ID: 3440640
[TBL] [Abstract][Full Text] [Related]
18. [Ceftriaxone, a cephalosporin with high hepatic elimination. Evaluation of its biliary clearance in man. Therapeutic value].
Brogard JM; Jehl F; Paris-Bockel D; Sini F; Blickle JF; Adloff M; Monteil H
Schweiz Med Wochenschr; 1987 Oct; 117(40):1549-59. PubMed ID: 3672089
[TBL] [Abstract][Full Text] [Related]
19. A comparative analysis of pharmacokinetics of ceftriaxone in serum and pleural fluid in humans: a study of once daily administration by intramuscular and intravenous routes.
Goonetilleke AK; Dev D; Aziz I; Hughes C; Smith MJ; Basran GS
J Antimicrob Chemother; 1996 Dec; 38(6):969-76. PubMed ID: 9023644
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal pharmacokinetics and retinal concentrations of ganciclovir and foscarnet after intravitreal administration in rabbits.
López-Cortés LF; Pastor-Ramos MT; Ruiz-Valderas R; Cordero E; Uceda-Montañés A; Claro-Cala CM; Lucero-Muñoz MJ
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1024-8. PubMed ID: 11274081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
